期刊文献+

三氧化二砷治疗多发性骨髓瘤作用机制研究进展

下载PDF
导出
出处 《华西医学》 CAS 2006年第4期874-875,共2页 West China Medical Journal
  • 相关文献

参考文献24

  • 1Attal M,Harousseau J,Stoppa A,et al.A prospective,randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma[J].N Engl J Med,1996,335:91-97. 被引量:1
  • 2Anderson KC,Kyle RA,Berenson JR,et al.Recent advances in the biology and treatment of multiple myeloma[J].Washington,DC:American Society of Hematology Education Program,1998:63-88. 被引量:1
  • 3Liu,Hilsenbeck,Gazitt.Arsenic trioxide-induced apoptosis in myeloma cells:p53-dependent G1 or G2/M cell cycle arrest,activation of caspase-8 or caspase-9,and synergy with APO2/TRAIL[J].Blood,2003,101(10):4078-87. 被引量:1
  • 4Rousselot,Labaume,Marolleau,et al.Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients[J].Cancer-Res,1999,59(5):1041-8. 被引量:1
  • 5Cantoni O,Hussain S,Guidarelli A,et al.Cross-resistance to heavy metals in hydrogen peroxide-resistant CHO cell variants[J].Mutat.Res,1994,324:1-6. 被引量:1
  • 6Yang CH,Kuo ML,Chen YC.Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells[J].Br J Cancer,1999,81:796-799. 被引量:1
  • 7Lo JF,Wang HF,Tam MF,et al.Protein glutathione S-transferase π in an arsenic-resistant Chinese hamster ovary cell line[J].Biochem J,1992,288(pt3):977-982. 被引量:1
  • 8Scott N,Hatlelid KM,MacKenzie NE,et al.Reactions of arsenic(111)and arsenic (V) species with glutathione[J].Chem Res Toxicol,1993,6:102-106. 被引量:1
  • 9Grad,Bahlis,Reis,et al.Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells[J].Blood,2001,98(3):805-13. 被引量:1
  • 10Griffith O W,Meister A.Potent and specific inhibition of glutathione synthesis by butathione sulfoximien (S-n-butyl homocystein sulfoximne)[J].J Biol Chem 1979,254:7558-7560. 被引量:1

二级参考文献19

  • 1Chen G Q,Chin J Integr Tradit West Med,1999年,5卷,82页 被引量:1
  • 2Akao Y,FEBS Lett,1999年,455卷,59页 被引量:1
  • 3Zhu X H,J Natl Cancer Inst,1999年,91卷,772页 被引量:1
  • 4Gurr J R,Mol Pharmacol,1999年,56卷,102页 被引量:1
  • 5Gianni M,Blood,1998年,91卷,4300页 被引量:1
  • 6Shao W,J Natl Cancer Inst,1998年,90卷,124页 被引量:1
  • 7Chen G Q,Blood,1996年,88卷,1052页 被引量:1
  • 8LandowskiTH,QuN,BuyuksalI,etal.Mutationsinthefasantigeninpatientswithmultiplemyeloma[J].Blood,1997,90(11):4266-4270. 被引量:1
  • 9TuY,RennerS,XUF,etal.Bcl-Xexpressioninmultiplemyeloma:possibleindicatorofchemoresistanse[J].CancerRes,1998,58:(2)25-262. 被引量:1
  • 10ShenZX,ChenGQ,NiJH,etal.UseofAs2O3intreatmentofacutepromyelocyticleukemia:II.clinicalefficacyandpharmacokineticsinrelapsedpatients[J].Blood,1997,89(9):3354-3360. 被引量:1

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部